MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled
About Knight Therapeutics Inc. Read More
Related
Share this page
Guest Posts by Easy Branches